title: Factors associated with declining a rapid human immunodeficiency virus test in labor and delivery.
abstract: The Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists recommend routine rapid HIV testing in labor and delivery (L&D) for women with undocumented HIV status using an opt-out approach. Identifying factors associated with declining a rapid HIV test in L&D will be helpful in developing strategies to improve rapid HIV testing uptake. Data from the Mother-Infant Rapid Intervention at Delivery study were analyzed. Women ≥24 weeks gestation, in labor, with undocumented HIV status were offered rapid HIV testing using informed consent. Women who declined rapid HIV testing (decliners) but agreed to be interviewed were compared to women who accepted testing (acceptors). 102 decliners and 478 acceptors met inclusion criteria for analysis. Decliners of rapid HIV testing were more likely to have had prenatal care (PNC), after adjusting for age, Hispanic ethnicity, high-school education and city of enrollment (adjusted OR 2.4, 95% CI 1.06-5.58). Having had PNC was collinear with prior HIV education and previous offer of an HIV test during the current pregnancy, so these factors were not part of the model. During PNC, standard informed consent may involve discussions that negatively affect later uptake of testing in L&D. Therefore an opt-out approach to testing may improve testing rates. Furthermore, decliners may have felt that testing in L&D was redundant because of previous testing during PNC; however, if previous testing occurred, this was undocumented at L&D. Documentation and timely communication of HIV status is critical to provide appropriate HIV prophylaxis.
authors.affiliation: Division of Parasitic Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. kit4@cdc.gov
authors.forename: Kathrine R
authors.initials: KR
authors.lastname: Tan
authors.forename: Margaret A
authors.initials: MA
authors.lastname: Lampe
authors.forename: Susan P
authors.initials: SP
authors.lastname: Danner
authors.forename: Patricia
authors.initials: P
authors.lastname: Kissinger
authors.forename: Mayris P
authors.initials: MP
authors.lastname: Webber
authors.forename: Mardge H
authors.initials: MH
authors.lastname: Cohen
authors.forename: Mary Jo
authors.initials: MJ
authors.lastname: O'Sullivan
authors.forename: Steven
authors.initials: S
authors.lastname: Nesheim
authors.forename: Denise J
authors.initials: DJ
authors.lastname: Jamieson
mesh_terms: D015492:AIDS Serodiagnosis / Q000379:methods*; D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood*; D036861:Delivery, Obstetric; D005260:Female; D015658:HIV Infections / Q000175:diagnosis*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D007258:Informed Consent; D007407:Interviews as Topic; D007743:Labor, Obstetric; D010342:Patient Acceptance of Health Care / Q000523:psychology*; D011237:Predictive Value of Tests; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis* / Q000821:virology; D011295:Prenatal Care; D012959:Socioeconomic Factors; D055815:Young Adult
chemical_list: D000914:Antibodies, Viral